PMC:7441788 / 3515-4209
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T11 | 95-99 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T12 | 459-464 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T40 | 86-94 | Disease | denotes | hepatoma | http://purl.obolibrary.org/obo/MONDO_0007256 |
T41 | 484-493 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T42 | 574-583 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T25 | 14-22 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T26 | 80-85 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T27 | 95-104 | http://purl.obolibrary.org/obo/CLO_0000031 | denotes | cell line |
T28 | 106-111 | http://purl.obolibrary.org/obo/CLO_0051864 | denotes | Huh-7 |
T29 | 452-464 | http://purl.obolibrary.org/obo/CLO_0051719 | denotes | VeroE6 cells |
T30 | 509-514 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T31 | 639-644 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T42 | 4-13 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T43 | 26-28 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T44 | 301-303 | Chemical | denotes | SI | http://purl.obolibrary.org/obo/CHEBI_90326 |
T45 | 368-370 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T46 | 446-448 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T47 | 541-543 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T48 | 619-621 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T27 | 26-28 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T28 | 368-370 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T29 | 446-448 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T30 | 541-543 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T31 | 619-621 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T37 | 37-45 | Species | denotes | MERS-CoV | NCBItxid:1335626 |
T38 | 50-59 | Species | denotes | HCoV-229E | NCBItxid:11137 |
T39 | 80-85 | Species | denotes | human | NCBItxid:9606 |
T40 | 406-414 | Species | denotes | MERS-CoV | NCBItxid:1335626 |
T41 | 475-483 | Species | denotes | MERS-CoV | NCBItxid:1335626 |
T42 | 565-573 | Species | denotes | MERS-CoV | NCBItxid:1335626 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T32 | 0-367 | Sentence | denotes | The antiviral activity of CQ against MERS-CoV and HCoV-229E was assessed in the human hepatoma cell line (Huh-7) and found that the 50% effective concentrations (EC50) were 3.0(±1.1) μM and 3.3(±1.2) μM, the 50% cytotoxic concentrations (CC50) were 58.1(±1.1) μM and >50, and the selectivity indexes (SI; calculated as CC50/EC50) were 19.4 and >15, respectively [10]. |
T33 | 368-433 | Sentence | denotes | CQ could inhibit an early step in the MERS-CoV replication cycle. |
T34 | 434-526 | Sentence | denotes | Addition of CQ to VeroE6 cells 1 h after MERS-CoV infection did not affect virus production. |
T35 | 527-694 | Sentence | denotes | However, when CQ was added 1 h before MERS-CoV infection, 16 μm and 32 μM concentrations of CQ could reduce the virus production of 1-log and 2-log, respectively [10]. |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
154 | 200-202 | Gene | denotes | μM | Gene:56925 |
155 | 260-262 | Gene | denotes | μM | Gene:56925 |
156 | 598-600 | Gene | denotes | μM | Gene:56925 |
157 | 588-590 | Gene | denotes | μm | Gene:56925 |
158 | 183-185 | Gene | denotes | μM | Gene:56925 |
159 | 37-45 | Species | denotes | MERS-CoV | Tax:1335626 |
160 | 50-59 | Species | denotes | HCoV-229E | Tax:11137 |
161 | 80-85 | Species | denotes | human | Tax:9606 |
162 | 406-414 | Species | denotes | MERS-CoV | Tax:1335626 |
163 | 368-370 | Chemical | denotes | CQ | MESH:D002738 |
164 | 446-448 | Chemical | denotes | CQ | MESH:D002738 |
165 | 541-543 | Chemical | denotes | CQ | MESH:D002738 |
166 | 619-621 | Chemical | denotes | CQ | MESH:D002738 |
167 | 86-94 | Disease | denotes | hepatoma | MESH:D006528 |
168 | 475-493 | Disease | denotes | MERS-CoV infection | MESH:D018352 |
169 | 570-583 | Disease | denotes | CoV infection | MESH:D018352 |
170 | 106-111 | CellLine | denotes | Huh-7 | CVCL:0336 |
171 | 452-458 | CellLine | denotes | VeroE6 | CVCL:0574 |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T20 | 4-13 | http://purl.obolibrary.org/obo/IDO_0000559 | denotes | antiviral |
T21 | 95-99 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cell |
T22 | 415-426 | http://purl.obolibrary.org/obo/IDO_0000608 | denotes | replication |
T23 | 459-464 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cells |
T24 | 484-493 | http://purl.obolibrary.org/obo/IDO_0000586 | denotes | infection |
T25 | 509-514 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T26 | 515-525 | http://purl.obolibrary.org/obo/IDO_0000607 | denotes | production |
T27 | 574-583 | http://purl.obolibrary.org/obo/IDO_0000586 | denotes | infection |
T28 | 639-644 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T29 | 645-655 | http://purl.obolibrary.org/obo/IDO_0000607 | denotes | production |
LitCovid-sample-PD-FMA
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T11 | 95-99 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T12 | 459-464 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T34 | 86-94 | Disease | denotes | hepatoma | http://purl.obolibrary.org/obo/MONDO_0007256 |
T35 | 484-493 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T36 | 574-583 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
154 | 200-202 | Gene | denotes | μM | Gene:56925 |
155 | 260-262 | Gene | denotes | μM | Gene:56925 |
156 | 598-600 | Gene | denotes | μM | Gene:56925 |
157 | 588-590 | Gene | denotes | μm | Gene:56925 |
158 | 183-185 | Gene | denotes | μM | Gene:56925 |
159 | 37-45 | Species | denotes | MERS-CoV | Tax:1335626 |
160 | 50-59 | Species | denotes | HCoV-229E | Tax:11137 |
161 | 80-85 | Species | denotes | human | Tax:9606 |
162 | 406-414 | Species | denotes | MERS-CoV | Tax:1335626 |
163 | 368-370 | Chemical | denotes | CQ | MESH:D002738 |
164 | 446-448 | Chemical | denotes | CQ | MESH:D002738 |
165 | 541-543 | Chemical | denotes | CQ | MESH:D002738 |
166 | 619-621 | Chemical | denotes | CQ | MESH:D002738 |
167 | 86-94 | Disease | denotes | hepatoma | MESH:D006528 |
168 | 475-493 | Disease | denotes | MERS-CoV infection | MESH:D018352 |
169 | 570-583 | Disease | denotes | CoV infection | MESH:D018352 |
170 | 106-111 | CellLine | denotes | Huh-7 | CVCL:0336 |
171 | 452-458 | CellLine | denotes | VeroE6 | CVCL:0574 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T32 | 0-367 | Sentence | denotes | The antiviral activity of CQ against MERS-CoV and HCoV-229E was assessed in the human hepatoma cell line (Huh-7) and found that the 50% effective concentrations (EC50) were 3.0(±1.1) μM and 3.3(±1.2) μM, the 50% cytotoxic concentrations (CC50) were 58.1(±1.1) μM and >50, and the selectivity indexes (SI; calculated as CC50/EC50) were 19.4 and >15, respectively [10]. |
T33 | 368-433 | Sentence | denotes | CQ could inhibit an early step in the MERS-CoV replication cycle. |
T34 | 434-526 | Sentence | denotes | Addition of CQ to VeroE6 cells 1 h after MERS-CoV infection did not affect virus production. |
T35 | 527-694 | Sentence | denotes | However, when CQ was added 1 h before MERS-CoV infection, 16 μm and 32 μM concentrations of CQ could reduce the virus production of 1-log and 2-log, respectively [10]. |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32496926-24841269-132195655 | 363-365 | 24841269 | denotes | 10 |
32496926-24841269-132195656 | 690-692 | 24841269 | denotes | 10 |